Overview

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial was to evaluate the safety and feasibility of using a vaginal ring to deliver the candidate microbicide TMC120 (dapivirine). Twelve women initially underwent 7-day exposure to a placebo ring containing no investigational agent. They then underwent 7-day exposure to a ring containing 120 mg of TMC120 (dapivirine). Feasibility was assessed in terms of safety and tolerability as well as drug delivery.
Phase:
Phase 1
Details
Lead Sponsor:
International Partnership for Microbicides, Inc.
Collaborator:
Tibotec Pharmaceutical Limited
Treatments:
Dapivirine